1,779
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Molecular docking of immunogenic peptide of Toxoplasma gondii and encapsulation with polymer as vaccine candidate

, , &
Pages 744-754 | Received 22 Jan 2018, Accepted 20 Apr 2018, Published online: 09 May 2018

References

  • Liu Q, Singla LD, Zhou H. Vaccines against Toxoplasma gondii: status, challenges and future directions. Hum Vac Immunother. 2012;8:1305–1308.
  • Cakir-Koc R, Özdemir B. A global problem of toxoplasmosis. In: The microbiology of central nervous system infections. London (UK): Elsevier; 2018. p. 305–317.
  • Hill DE, Chirukandoth S, Dubey J. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005;6:41–61.
  • Burg JL, Perelman D, Kasper LH, et al. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol. 1988;141:3584–3591.
  • Beghetto E, Spadoni A, Bruno L, et al. Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products. J Clin Microbiol. 2006;44:2133–2140.
  • Makioka A, Suzuki Y, Kobayashi A. Recognition of tachyzoite and bradyzoite antigens of Toxoplasma gondii by infected hosts. Infect Immun. 1991;59:2763–2766.
  • Ahmad Fuaad AAH, Jia Z, Zaman M, et al. Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine. Nanomedicine (Lond). 2014;9:35–43.
  • Chang TM. Bioencapsulation in biotechnology. Biomater Artif Cells Immobil Biotechnol. 1993;21:291–297.
  • Asadi N, Davaran S, Panahi Y, et al. Application of nanostructured drug delivery systems in immunotherapy of cancer: a review. Artif Cells Nanomed Biotechnol. 2017;45:18–23.
  • Froimowitz M. HyperChem: a software package for computational chemistry and molecular modeling. J Comput Chem. 1993;14:934–1013.
  • Gorjikhah F, Azizi Jalalian F, Salehi R, et al. Preparation and characterization of PLGA-β-CD polymeric nanoparticles containing methotrexate and evaluation of their effects on T47D cell line. Artif Cells Nanomed Biotechnol. 2017;45:432–440.
  • Budama-Kilinc Y, Cakir-Koc R, Horzum-Bayir O. The cytotoxicity, characteristics, and optimization of insulin loaded nanoparticles. Orbital: Electron J Chem. 2017;9:1–6.
  • Gharaati-Far N, Tohidkia MR, Dehnad A, et al. Efficiency and cytotoxicity analysis of cationic lipids-mediated gene transfection into AGS gastric cancer cells. Artif Cells Nanomed Biotechnol. 2017. Forthcoming. doi:10.1080/21691401.2017.1355311
  • Mitaksov V, Fremont DH. Structural definition of the H-2Kd peptide-binding motif. J Biol Chem. 2006;281:10618–10625.
  • Fremont DH, Stura EA, Matsumura M, et al. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci. 1995;92:2479–2483.
  • Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455–461.
  • DeLano WL. Pymol: an open-source molecular graphics tool. CCP4 Newslett Protein Crystallogr. 2002;40:82–92.
  • Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605–1612.
  • Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3:1377–1397.
  • Erbetta CDAC, Alves RJ, Resende JM, et al. Synthesis and characterization of poly(dl-lactide-co-glycolide) copolymer. J Biomater Nanobiotechnol. 2012;3:208.
  • Gumusderelioglu M, Deniz G. Synthesis, characterization and in vitro degradation of poly(dl-lactide)/poly(dl-lactide-co-glycolide) films. Turk J Chem. 1999;23:153–162.
  • López-García J, Lehocký M, Humpolíček P, et al. HaCaT keratinocytes response on antimicrobial atelocollagen substrates: extent of cytotoxicity, cell viability and proliferation. JFB. 2014;5:43–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.